36,164 video views
Loading........
Description: Greg Van Wyk Noxopharm Chief Medical Officer Discusses Veyonda In Depth, Enhancing Chemo & Radiotherapies.
04:55
Greg Van Wyk Noxopharm Chief Medical Officer Discusses Veyonda In Depth, Enhancing Chemo & Radiotherapies.
by:Cancer-News | 272 views
03:10
Greg Van Wyk Noxopharm Chief Medical Officer Discusses Veyonda & Isoflavonoid Studies.
by:Cancer-News | 95 views
04:31
Greg Van Wyk Noxopharm Chief Medical Officer Discusses Veyondas Future In NSCLC, Sarcomas & Prostate Cancer.
by:Cancer-News | 206 views
03:32
Greg Van Wyk Noxopharm Chief Medical Officer Discusses Developing Isoflavone Idronoxil For Oncology Purposes.
by:Cancer-News | 122 views
03:46
Christopher Haqq M.D., PhD Executive Vise President Of Atara Biotherapeutics Discusses Engineering EBV Specific T cells.
by:Cancer-News | 62 views
05:45
Christopher Haqq M.D., PhD Executive Vise President Of Atara Biotherapeutics Discusses Mesothelin Targeted CAR-T Study.
by:Cancer-News | 138 views
02:04
Christopher Haqq M.D., PhD Executive Vise President Of Atara Biotherapeutics Discusses Subset Of 11 Mesothelioma Patients.
by:Cancer-News | 19 views
02:23
Scott Kopetz M.D., PhD., FACP Associate Professor, Department of Gastrointestina​l (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX Discusses
by:Cancer-News | 92 views
01:59
Scott Kopetz M.D., PhD., FACP Associate Professor, Department of Gastrointestina​l (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX Discusses Understanding Early Onset Colorectal Cancer.
by:Cancer-News | 142 views
02:08
Scott Kopetz M.D., PhD., FACP Associate Professor, Department of Gastrointestina​l (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX Discusses Increasing Incidences In Colorectal Cancer.
by:Cancer-News | 138 views

About Cancer-News


Links
Channel Url: